RDHL has been in the news 346% more than usual
Jul 24, 2025, 6:33 PM
-29.58%
What does RDHL do
RedHill Biopharma develops medicines for gastrointestinal and infectious diseases, promoting drugs like Talicia for H. pylori infections and Aemcolo for travelers’ diarrhea. Their late-stage programs include RHB-204, opaganib, RHB-107, RHB-104, and RHB-102.
RDHL has been in the news recently: Redhill Biopharma is not directly mentioned in the provided information, but it is relevant to note that Theravance Biopharma will participate in the BTIG Virtual Biotechnology Conference on July 30, 2025. Additionally, a survey reveals that while 64% of companies invest in AI, only 32% feel confident in using scientific data effectively.
📡️ Health Care
In The News
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.